Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial.
Kalinsky K, Bianchini G, Hamilton E, Graff SL, Park KH, Jeselsohn R, Martin M, Layman RM, Hurvitz SA, Sammons S, Kaufman PA, Muñoz M, Lai JI, Knoderer H, Sandoval C, Chawla AR, Nguyen B, Zhou Y, Ravenberg E, Litchfield LM, Smyth L, Wander SA.
Kalinsky K, et al. Among authors: zhou y.
J Clin Oncol. 2024 Dec 18:JCO2402086. doi: 10.1200/JCO-24-02086. Online ahead of print.
J Clin Oncol. 2024.
PMID: 39693591